Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 142-78-9 | MDL No. : | MFCD00020561 |
Formula : | C14H29NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | QZXSMBBFBXPQHI-UHFFFAOYSA-N |
M.W : | 243.39 | Pubchem ID : | 8899 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.93 |
Num. rotatable bonds : | 13 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 73.58 |
TPSA : | 49.33 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -4.93 cm/s |
Log Po/w (iLOGP) : | 3.49 |
Log Po/w (XLOGP3) : | 4.02 |
Log Po/w (WLOGP) : | 3.02 |
Log Po/w (MLOGP) : | 2.4 |
Log Po/w (SILICOS-IT) : | 3.65 |
Consensus Log Po/w : | 3.32 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 1.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.02 |
Solubility : | 0.231 mg/ml ; 0.000947 mol/l |
Class : | Soluble |
Log S (Ali) : | -4.76 |
Solubility : | 0.00424 mg/ml ; 0.0000174 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -4.56 |
Solubility : | 0.00675 mg/ml ; 0.0000277 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 3.0 |
Synthetic accessibility : | 2.0 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 120-40-1 ]
N,N-Bis(2-hydroxyethyl)dodecanamide
Similarity: 0.91
[ 6334-25-4 ]
N1,N1,N6,N6-Tetrakis(2-hydroxyethyl)adipamide
Similarity: 0.91
[ 24309-97-5 ]
N-(2-Hydroxyethyl)-3-oxobutanamide
Similarity: 0.85
[ 120-40-1 ]
N,N-Bis(2-hydroxyethyl)dodecanamide
Similarity: 0.91
[ 6334-25-4 ]
N1,N1,N6,N6-Tetrakis(2-hydroxyethyl)adipamide
Similarity: 0.91
[ 17342-08-4 ]
(S)-(+)-5-Hydroxymethyl-2-pyrrolidinone
Similarity: 0.85
[ 120-40-1 ]
N,N-Bis(2-hydroxyethyl)dodecanamide
Similarity: 0.91
[ 6334-25-4 ]
N1,N1,N6,N6-Tetrakis(2-hydroxyethyl)adipamide
Similarity: 0.91
[ 120-40-1 ]
N,N-Bis(2-hydroxyethyl)dodecanamide
Similarity: 0.91
[ 6334-25-4 ]
N1,N1,N6,N6-Tetrakis(2-hydroxyethyl)adipamide
Similarity: 0.91
[ 24309-97-5 ]
N-(2-Hydroxyethyl)-3-oxobutanamide
Similarity: 0.85